RE: Diabetic Boot Company26 Oct 2016 19:57
This report does date from July 2015, and we do not know at what value the company will come to market, but do like the following extracts from the investment report:
Assuming a high discount rate of 40% and a market share of just 5%, we estimate the shares could be worth £30.61, which suggests upside of 129% from the current price.
Competition:
While there are numerous clinical trials ongoing in the US for treating DFUs, we did not identify any trials for products similar to Pulseflow DF. Furthermore, to date, no other marketed devices have been identified which combine offloading and intermittent plantar compression.
Valuation:
Also, assuming a lower discount rate of 30%, this would translate to a target price of £63.59, or upside of 376%. The company expects to exit in 3-5 years via a trade sale or IPO.
The company's shares are currently privately traded.